期刊文献+

异基因免疫治疗中控制GVHD发生的研究进展 被引量:3

Allogeneic Immune Therapy in the Research on Controlling GVHD Occurrence
分享 导出
摘要 目前,异基因造血干细胞移植(allo-HSCT)已成为治疗某些恶性血液病的有效手段之一,然而伴随其而来的移植物抗宿主病(GVHD)是导致移植后患者死亡的重要并发症之一。因此,如何诱导移植后免疫耐受来控制GVHD,尤其是控制急性移植物抗宿主病(a GVHD)的发生及已成为研究的重要内容。GVHD的发生机制非常复杂,但最终为供者骨髓内的成熟T淋巴细胞识别受者体内的细胞表面的MHC-I和MHC-II及所递呈的多肽而导致供者的T细胞的激活、增殖并浸润到GVHD的靶器官如皮肤、小肠及肝脏并导致靶器官的损伤[1]。临床移植学和移植免疫学主要攻克的内容之一就是如何控制GVHD的发生发展。其预防和治疗是决定着同种异基因造血干细胞移植(allo-HSCT)是否成功的关键所在,移植个体是否长期存活的主要因素之一。本文章就导致GVHD现象的原因及最新进展做一总结。 Allogeneic hematopoietic stem cell transplantation has become one of the effective means of treatment of certain malignancies. But with its of graft versus host disease(GVHD) is one of the important complications of death patients after transplantation.Therefore, how to induce GVHD after transplantation immune tolerance to control, especially control the occurrence of acute graft versus host disease(a GVHD) has become an important part of the study. The occurrence of GVHD mechanism is very complicated. But ultimately identify for mature T cells within the bone marrow donor recipient cells on the surface of the MHC- I and MHC II and caused peptides presented by donor T cell activation, proliferation and infiltration of GVHD target organs such as skin, small intestine and the liver and lead to target organs damage. Clinical implantology and transplantation immunology is one of the contents of the main crack how to control the occurrence of GVHD development. The prevention and treatment is the key to success of allogeneic hematopoietic stem cell transplantation. Individual transplantation is one of the main factors of long-term survival. Related cytokines application and related mechanism research, to a great extent, effective control of the development of GVHD. such as CD4+CD25+Tregs, ecto-59-nucleotidase(CD73), natural killer cell(NK cells), Granulocyte colony-stimulating-factor(G-CSF), Mesenchymal stem cells(MSC), Inducible T cell costimnlator(ICOS) and so on.This article about the cause of GVHD phenomenon and summarize the latest progress.
作者 姜峰奇 姜涛 张哲男 赵志威 侯国伟 朴大勋 JIANG Feng-qi, JIANG Tao, ZHANG Zhe-nan, ZHAO Zhi-wei, HOU Guo-wci, PIAO Da-xun (Department of general surgery, First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, 150001, China)
出处 《现代生物医学进展》 CAS 2015年第9期1760-1763,共4页 Progress in Modern Biomedicine
基金 国家自然科学基金项目(30972878) 黑龙江省自然科学基金项目(D201218)
关键词 GVT GVHD CD4+CD25+调节性T细胞 CD73 NK细胞 可诱导共刺激分子 间充质干细胞 G-CSF GVT GVHD CD4+CD225+Tregs CD73 NK cells ICOS G-CSF MSC
作者简介 姜峰奇(1986-),男,硕士研究生,住院医师,主要研究方向大肠癌的治疗,E-mail:jiangfengqi2012@126.com 通讯作者:朴大勋,男,主任医师、科主任,主要研究方向大肠癌的治疗,E-mail:piaodaxun@sina.com
  • 相关文献

参考文献2

二级参考文献45

  • 1赵振林,郭永章,李立,张捷.T细胞疫苗免疫前后外周血CD4~+和CD8~+T细胞变化的分析[J].免疫学杂志,2003(S1):27-30. 被引量:3
  • 2Pardoll D.Does the immune system see tumors as foreign or self? Annu Rev Immunol 2003; 21:807-839. 被引量:1
  • 3Rabinovich GA,Gabrilovich D,Sotomayor EM.Immunosuppressive strategies that are mediated by tumor cells.Annu Rev Immunol 2007; 25:267-296. 被引量:1
  • 4Gabrilovich DI,Nagaraj S.Myeloid-derived suppressor cells as regulators of the immune system.Nat Rev Immunol 2009; 9: 162-174. 被引量:1
  • 5Li X,Kostareli E,Suffner J,Garbi N,H mmerling GJ.Efficient Treg depletion induces T-cell infiltration and rejection of large tumors.Eur J Immunol 2010; 40:3325-3335. 被引量:1
  • 6Poehlein CH,Haley DP,Walker EB,Fox BA.Depletion of tumor-induced Treg prior to reconstitution rescues enhanced priming of tumor-specific,therapeutic effector T cells in lymphopenic hosts.Eur J Immunol 2009; 39:3121-3133. 被引量:1
  • 7Yuan XL,Chen L,Li MX,Dong P,Xue J,Wang J,Zhang TT, Wang XA,Zhang FM,Ge HL,Shen LS,Xu D.Elevated expression of Foxp3 in tumor-infiltrating Treg cells suppresses T-cell proliferation and contributes to gastric cancer progression in a COX-2-dependent manner.Clin Immunol 2010; 134: 277-288. 被引量:1
  • 8Antony PA,Piccirillo CA,Akpinarli A,Finkelstein SE,Speiss PJ,Surman DR,Palmer DC,Chan CC,Klebanoff CA,Overwijk WW,Rosenberg SA,Restifo NP.CD8+ T cell immunity against a tumor/self-antigen is augmented by CD4+ T helper cells and hindered by naturally occurring T regulatory cells.J Immunol 2005; 174:2591-2601. 被引量:1
  • 9Jacobs JF,Idema AJ,Bol KF,Grotenhuis JA,de Vries IJ,Wesseling P,Adema GJ.Prognostic significance and mechanism of Treg infiltration in human brain tumors.J Neuroimmunol 2010; 225:195-199. 被引量:1
  • 10Curiel TJ,Coukos G,Zou L,Alvarez X,Cheng P,Mottram P, Evdemon-Hogan M,Conejo-Garcia JR,Zhang L,Burow M, Zhu Y,Wei S,Kryczek I,Daniel B,Gordon A,Myers L,Lackner A,Disis ML,Knutson KL,Chen L,Zou W.Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival.Nat Med 2004; 10:942-949. 被引量:1

共引文献6

同被引文献16

引证文献3

二级引证文献2

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈